In 2024, 62% of FDA Form 483 observations at biotech facilities cited equipment qualification, calibration, or maintenance documentation failures as root causes. A single contamination event in a 2,000L bioreactor campaign averages $8.4M in batch loss, regulatory investigation, and CAPA burden. Book a demo to see how Oxmaint manages bioreactor, chromatography, UF/DF, and fill-finish maintenance under 21 CFR Part 11 validated controls.
Biotech manufacturing carries four equipment categories where maintenance gaps translate directly to batch risk and FDA enforcement exposure: bioreactors, chromatography skids, UF/DF systems, and fill-finish isolators. Oxmaint validates every calibration, PM, and deviation against 21 CFR Part 11 electronic records — connecting field execution to audit-ready documentation without paper transfer.
Equipment Risk Categories
Stainless steel and single-use bioreactors require validated cleaning, sterilization cycle qualification, and sensor calibration before every campaign. Oxmaint manages qualification calendars, captures calibration certificates per sensor tag, and blocks batch start when any qualification status is non-current.
Column integrity testing, UV calibration, and resin lifecycle tracking against validated cycle limits are mandatory. Oxmaint tracks resin counts per column, automates integrity scheduling, and routes extension study approvals through validated electronic signatures.
Cassette integrity testing, TMP calibration, and cleaning validation per membrane lot must be documented before each run. Oxmaint links integrity records to membrane serial numbers and blocks work order completion until all pass criteria are captured.
VHP decontamination, HEPA integrity, glove leak testing, and environmental monitoring must be current before every aseptic fill. Oxmaint manages CCS-linked PM schedules and produces Annex 1-aligned qualification evidence on demand.
Every Calibration. Every Qualification. Every Integrity Test — Validated Electronic Record.
Book a demo to see validated maintenance workflow for your drug substance suite.
Deployment Roadmap
All bioreactors, chromatography skids, UF/DF systems, and isolators registered with GMP criticality, IQ/OQ/PQ status, calibration tag inventory, and procedure references. Historical paper logs mapped to Oxmaint asset structure.
PM work orders and calibration routines configured as 21 CFR Part 11-compliant records with two-level electronic signatures. Calibration certificates captured directly against sensor tag IDs — no paper transcription. Book a demo to see validated PM workflow for bioreactor calibration.
Qualification gate logic connected to MES/ERP campaign authorization — batches cannot advance when linked equipment has overdue calibration, expired qualification, or open critical deviation. QA escalation routing configured.
FDA, EMA, PMDA, and MHRA inspection packages assembled in under 4 hours. Annex 1 CCS evidence produced automatically. Executive compliance dashboard active across all biotech manufacturing sites.
Global Regulatory Coverage
| Jurisdiction | Primary Frameworks | Equipment Documentation Required | Oxmaint Coverage |
|---|---|---|---|
| USA (FDA) | 21 CFR 210/211/600, Part 11; FDA Process Validation (2011); ICH Q7–Q10 | IQ/OQ/PQ records, NIST-traceable calibration certs, PM execution evidence, deviation and CAPA records | Part 11 validated records, two-level e-signatures, NIST calibration management, CAPA closure with 21 CFR audit trail |
| EU (EMA) | Annex 1 (2022), Annex 11, Annex 15, EudraLex Vol. 4 | CCS documentation, Annex 11 validated systems, requalification calendars, lifecycle management | CCS-linked PM scheduling, Annex 11 validation package, requalification calendars, lifecycle records |
| UK (MHRA) | UK GMP Orange Guide, MHRA Data Integrity (ALCOA+), Human Medicines Regulations 2012 | ALCOA+ compliant records, contemporaneous execution evidence, attributable e-signatures | ALCOA+ data integrity, contemporaneous mobile capture, attributable signatures, MHRA inspection export |
| Japan (PMDA) | Japanese GMP Ordinance, PMDA Data Integrity, PIC/S GMP, Biological Products Regulations | Japanese-language equipment records, PMDA inspection documentation, data integrity controls | Multilingual records (JP/EN), PMDA-aligned inspection export, data integrity enforcement |
| Global | ICH Q7–Q11, WHO TRS 986, PIC/S GMP, GAMP 5 | Harmonized QMS records, risk-based qualification, lifecycle validation documentation | ICH Q10 lifecycle management, Q9 risk-based scheduling, GAMP 5 categorization, global inspection export |
FDA, EMA, MHRA, and PMDA — One Validated Maintenance Platform
Book a demo to see multi-region GMP configuration for your manufacturing network.
Platform vs. Alternatives
| Capability | Oxmaint | MaintainX | UpKeep | Fiix | Limble | IBM Maximo | Infor EAM |
|---|---|---|---|---|---|---|---|
| 21 CFR Part 11 validated records | Yes | No | No | Partial | No | Yes | Yes |
| Two-level e-signature workflow | Yes | No | No | Partial | No | Yes | Yes |
| Qualification gate / campaign block | Yes | No | No | No | No | Custom | Custom |
| Annex 1 CCS integration | Yes | No | No | No | No | Custom | Custom |
| Resin and membrane lifecycle tracking | Yes | No | No | No | No | Custom | Custom |
| Inspection export < 4 hours | Yes | No | No | Partial | No | Yes | Yes |
| Weeks to deploy (not months) | Yes | Yes | Yes | Varies | Yes | No | No |
Measured Outcomes
From 71% PM Compliance to 100% — in One Quarter
Book a demo to identify your current equipment qualification gap in the first session.
Platform Capabilities
Validated electronic records with two-level e-signatures, attributable audit trail, and change control for every GMP-critical work order and qualification event.
IQ/OQ/PQ status tracked per asset with automated requalification scheduling and gate logic that prevents campaign start on non-compliant equipment.
Calibration certificates captured against sensor tag IDs with NIST traceability, automated recalibration scheduling, and overdue-status blocking of dependent work orders.
Contamination Control Strategy documentation linked to isolator and aseptic line PM schedules — with Annex 1 evidence assembly for EMA and MHRA inspections.
Chromatography resin cycle counts and UF/DF membrane lifecycle tracked per column and cassette with validated electronic extension study approvals.
Real-time VP visibility into GMP equipment health, PM completion, qualification currency, and inspection readiness across all biotech manufacturing sites.
Frequently Asked Questions
Close the Documentation Gap Before the Next Inspection
Validated maintenance records, qualification lifecycle management, Annex 1 CCS integration, and executive compliance visibility — operational in 10–14 weeks. Start a free trial or schedule a briefing to review validated maintenance workflow for your manufacturing suite.
